Navigation Links
DSM Announces SafeBridge(R) Potent Compound Safety Certification
Date:8/5/2009

Director of Marketing President and Chief Executive Officer DSM Pharmaceuticals, Inc. Tel: +1 650 961 4820 ext 229 Tel: +1 512 569 9322 Email: john.farris@safebridge.com Email: david.linn@dsm.com

Forward-looking statements

This press release contains forward-looking statements. These statements are based on current expectations, estimates and projections of DSM management and information currently available to the company. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that its expectations will be realized. Furthermore, DSM has no obligation to update the statements contained in this press release.


'/>"/>
SOURCE DSM Pharmaceutical Products
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Misonix Announces the Sale of Its Labcaire Business for up to $5.6 Million
2. ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride
3. Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Senior Notes
4. Crisco(R) Announces the Crisco Live Smart, Cook Smarter Contest Winners
5. CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine
6. Samarion Announces Partnership With Adesta to Install the SamarionSolution Nationwide
7. EPIX Pharmaceuticals, Inc. Announces August 25, 2009 for the Auction Sale of Equipment and September 30, 2009 for the Auction Sale of the Intellectual Property
8. Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment
9. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 First Quarter Financial Results
10. Presidents Council Announces Top 5 Winners of 2009 National Presidents Challenge
11. Arcadia Resources Announces Webcast of Its Fiscal 2010 First Quarter Conference Call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...everybody, health care professionals enjoy a pay r...inancial incentives for health care performance ma... that patient-care performance ratings for 25 medi...y following the launch of a statewide pay-for-perf...ocused on doctors, productivity. , Reporting ...
(Date:11/23/2009)...ales saw their odds drop by 63 percent with modera..., Nov. 23 (HealthDay News) -- Moderate-to-high int...s may help reduce stroke risk in older men but not...uded almost 3,300 men and women, average age 69, i.... During that time, there were 238 strokes among t...
(Date:11/23/2009)...ships doubled number of patients who reined in the...Y, Nov. 23 (HealthDay News) -- High blood pressure...orking hand-in-hand than by doctors and pharmacist...sicians work with pharmacists, medications are int... effectively," said Barry L. Carter, a professor i...
(Date:11/23/2009)...oints up weaknesses of drug approval process in Un... Nov. 23 (HealthDay News) -- Problems with the pop...k for heart attack, stroke and death, were known f...om the market in 2004, a new report says. , Co...Co., dangerous side effects were evident in 2000, ...
(Date:11/23/2009)... CENTERCITY,Minn.,Nov.23/PRNewswire/--Hazelden,the...center,todayannouncedtheleadershipteamforitsnewrec...tyinNaplesisscheduledtoopeninlateMarch2010,andwill...s,includingafullarrayoffamilyandoutpatientservices...rectorofHazelden,sfacilityinNaples,withBrendaIliff...
Breaking Medicine News(10 mins):Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2
...fter 40, dizziness makes them 12 times more likely..., TUESDAY, May 26 (HealthDay News) -- About 69 mil...-ear dysfunction that causes dizziness and makes t...because they,ve had no previous incidents of dizzi...
... Researchers at the University of Maryland School...treating rheumatoid arthritis reduces severe illne...rus. Their findings suggest that tempering the res...The scientists report in the June 1 edition of Th...
... PROVIDENCE, RI A new study published online in ...at strict maternal control over eating habits suc...oaxing them to eat certain foods during early chi... weight. , "Our findings suggest that controlling...
... Pediatric dermatologist-researcher Alfred Lane, M...e a sign of ultraviolet radiation damage, warns La...D, knows that kids love summer and kids love sun. ...-UPcx , , (Photo: http://www.newscom.com/cgi-bi...
... Market Scope has announc...itions of two of its three comprehensive reports o...et Scope, this is a very exciting time in the reti...untreatable. Investigational devices are promising...
... Pre-opening event raises more than $1,000 for Fir..., May 26 LongHorn Steakhouse today announced the ...reet in Homestead, Fla. The Homestead location is... the restaurant recently hosted a Friends and Fami...
Other Medicine News:Health News:Inner Ear Dysfunction Puts Older Adults at Risk of Falls 2Health News:Arthritis drug might prove effective in fighting the flu, study suggests 2Health News:Arthritis drug might prove effective in fighting the flu, study suggests 3Health News:Strict maternal feeding practices not linked to child weight gain 2Health News:There's No Such Thing as a Good Tan 2Health News:There's No Such Thing as a Good Tan 3Health News:Market Scope Expects Retina Pharmaceutical Industry to Top $3.5 Billion by 2014 2Health News:Market Scope Expects Retina Pharmaceutical Industry to Top $3.5 Billion by 2014 3Health News:Market Scope Expects Retina Pharmaceutical Industry to Top $3.5 Billion by 2014 4Health News:LongHorn Steakhouse Brings the Spirit of the West to Homestead 2
(Date:11/23/2009)...,Nov.23/PRNewswire-USNewswire/--JubilantOrganosys,...nResearchInstitutetodayannouncedajointventurethatw...ablingtechnologiesintheareasofOncology,MetabolicDi...bitragedandleveragedpartnershipthatwillacceleratet...wide.AMemorandumofUnderstandingwassignedtodayinWas...
(Date:11/23/2009)...-BioTrendsResearchGroup,Inc.releasedWave2ofits La...lti-phasesyndicatedmarketresearchprojecttrackingth...efirstsixmonthsofproductavailability.Eachwaveofthe...ephrologistsandqualitativeinformationfromasubsetof...touse,reasonstouse,typicalpatienttypes,productperc...
(Date:11/23/2009)...rstCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:C...any( http://www.cordblood-america.com )focusedonbr...linsurancepolicy,tofamiliesnationwideandinternatio...withCEOandco-founderMatthewSchisslerisnowavailable...e/2875811 . ,, Intheinterview,Mr.Schisslerupdat...
Breaking Medicine Technology:Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 1Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 2Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 3Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16 2009 14777 1Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16 2009 14777 2PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 1PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 2PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 3PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 4PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 5PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 6
...to Timeline for Second Pivotal Phase 3 Trial CL-05... Advanced Life,Sciences Holdings, Inc. , today ann...ata from Trial CL-06, the first of two,pivotal Pha... and,effectiveness of cethromycin, a novel once-a-...uired pneumonia (CAP). The Company,also provided a...
..., July 2, 2007-Women with at least three sites of,...times more likely,than average women to develop br...c Cancer Center led study of women with atypical,h... 1 issue of the,Journal of Clinical Oncology., Sev...erplasia,(also called atypia) in breast tissue is ...
Other Medicine Technology:Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast,Cancer Risk Prediction in Women with Atypia 2Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast,Cancer Risk Prediction in Women with Atypia 3
...xperience the finest surgical-quality loupes avail...andard for innovative optical design, combining su...livering optimum performance with maximum comfort,...al professionals worldwide. All SheerVision loupes...
...xperience the finest surgical-quality loupes avail...andard for innovative optical design, combining su...ivering optimum performance with maximum comfort, ...l professionals worldwide. Make both a professiona...
...hese award-winning surgical loupes from SheerVisio...resolution optics combined with light-weight comfo...s weight as little as 1.5 ounces when included wit...in either a flip-up or through-the-lens (TTL) desi...
...heerVision is now the first manufacturer to offer ...he wearer. These next generation loupes feature ex...tra-lightweight design, and are multi-coated lens ...With SheerVision's proprietary SureFit system - yo...
Medicine Products: